Otsuka Holdings Co., Ltd. (OTSKF)
OTCMKTS
· Delayed Price · Currency is USD
44.40
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT
Otsuka Holdings Revenue
Otsuka Holdings had revenue of 597.93B JPY in the quarter ending June 30, 2025, with 1.44% growth. This brings the company's revenue in the last twelve months to 2.40T, up 10.17% year-over-year. In the year 2024, Otsuka Holdings had annual revenue of 2.33T with 15.42% growth.
Revenue (ttm)
2,401.70B JPY
Revenue Growth
+10.17%
P/S Ratio
1.69
Revenue / Employee
67.96M JPY
Employees
35,338
Market Cap
28.17B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
| Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
| Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
| Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
| Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Otsuka Holdings News
- 11 days ago - Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Otsuka Holdings Co., Ltd. (OTSKY) Q2 FY2024 Earnings Call Transcript - Seeking Alpha